Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PERIOP-FOLFIRINOX: A Pilot Trial of Perioperative Genotype-guided Irinotecan Dosing of gFOLFIRINOX for Locally Advanced Gastroesophageal Adenocarcinoma

NCT02366819 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT02366819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02366819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PERIOP-FOLFIRINOX: A Pilot Trial of Perioperative Genotype-guided Irinotecan Dosing of gFOLFIRINOX for Locally Advanced Gastroesophageal Adenocarcinoma
Lead sponsor
University of Chicago
Phase
Phase 4
Overall status
Suspended
Start date
December 11, 2014
Completion date
June 8, 2026
Enrollment
36 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal adenocarcinoma, gastric adenocarcinoma, stage iib gastric cancer, stage iiia esophageal adenocarcinoma, stage iiia gastric cancer, stage iiib esophageal adenocarcinoma, stage iiib gastric cancer, stage iiic esophageal adenocarcinoma, stage iiic gastric cancer